TLR4 and pneumonia: The comparison of the regulatory direction of TLR4 in COVID-19 pneumonia to COVID-19 ARDS showed inhibition of TLR4 by miR-146a-5p in pneumonia and upregulation in ARDS by downregulated let-7e-5p.